The RAGE connection to diabetes and atherosclerosis: an intertwined web of advanced glycation and inflammation

Author： Ramasamy Ravichandran   Yan Shi Fang   Schmidt Ann Marie  

Publisher： Future Medicine

ISSN： 1746-0875

Source： Future Lipidology, Vol.2, Iss.2, 2007-04, pp. : 239-250

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Increased Expression of the Receptor for Advanced Glycation End-Products (RAGE) Is Associated with Advanced Breast Cancer Stage

By  

Oncology Research and Treatment, Vol. 39, Iss. 10, 2016-09 ,pp. : 622-628

Karger

Access to resources Recommend Favorite

Advanced Glycation End Products Induce Calcification of Vascular Smooth Muscle Cells through RAGE/p38 MAPK

By  

Journal of Vascular Research, Vol. 46, Iss. 6, 2009-06 ,pp. : 572-580

Karger

Access to resources Recommend Favorite

Circulating Levels of Advanced Glycation End Products in Diabetes Mellitus–Related Dementia

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 63, Iss. 10, 2015-10 ,pp. : 2196-2198

John Wiley & Sons Inc

Access to resources Recommend Favorite

Advanced glycation end products increase expression of S100A8 and A9 via RAGE–MAPK in rat dental pulp cells

By  

ORAL DISEASES, Vol. 21, Iss. 3, 2015-04 ,pp. : 328-334

John Wiley & Sons Inc

Access to resources Recommend Favorite

Atorvastatin decreases serum levels of advanced glycation end products (AGEs) in patients with type 2 diabetes

By Jinnouchi Y.   Yamagishi S.   Takeuchi M.   Ishida S.   Jinnouchi Y.   Jinnouchi J.   Imaizumi T.  

Clinical and Experimental Medicine, Vol. 6, Iss. 4, 2006-12 ,pp. : 191-193

Springer Publishing Company

Access to resources Recommend Favorite